[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353883-105":59,"doc-detail-353883-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","dual-roles-of-immunosenescence-in-cancer-immunotherapy-review","Dual roles of immunosenescence in cancer immunotherapy - Review","","Cellular senescence of tumor-infiltrating immune cells is a hallmark of tumorigenesis, linked to functional decline and impaired antitumor immunity. Immunosenescence is not only a key biological feature of the tumor microenvironment but also a therapeutic target with dual regulatory potential. Although prior reviews addressed immunosenescence biomarkers and its relationship to aging and disease, detailed analyses of its specific dual roles in cancer immunotherapy outcomes remain limited. This review synthesizes bidirectional immune cell senescence-tumor progression interactions and highlights molecular mechanisms and potential targets for therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dual-roles-of-immunosenescence-in-cancer-immunotherapy-review/353883/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dual-roles-of-immunosenescence-in-cancer-immunotherapy-review/353883.png","ImageObject",300,407,{"name":92,"@type":93},"\tJames","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is immunosenescence in this review?","Question",{"text":112,"@type":113},"Immunosenescence is described as a progressive loss of proliferative capacity of immune cells under chronic stimulation, leading to a static state.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does immunosenescence relate to the tumor microenvironment (TME)?",{"text":117,"@type":113},"Within the TME, senescent immune cells lose tumor-targeting functionality while secreting SASP factors that can promote tumor proliferation, migration, and invasion.",{"name":119,"@type":110,"acceptedAnswer":120},"Why does immunosenescence have “dual roles” in cancer immunotherapy?",{"text":121,"@type":113},"The review emphasizes bidirectional interactions where senescent immune cells influence tumor progression, while senescent immune-cell functions also present therapeutic opportunities through modulation of their state.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353883,1790753645,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Review  \nPUBLISHED 06 March 2026  \nDOI 10.3389/fimmu.2026.1779141  \nOPEN ACCESS  \nEDITED BY  \nHua-Guo Xu,  \nNanjing Medical University, China  \nREVIEWED BY  \nAlex C.Y. Chen,  \nMassachusetts General Hospital, Harvard Medical School, United States  \nYue Liu,  \nCalico Life Sciences LLC, United States  \n*CORRESPONDENCE  \nLei Sun  \n[jinlsunlei@163.com](jinlsunlei@163.com)[ ](jinlsunlei@163.com)Jiawei Fan  \n[jiaweifan93@163.com](jiaweifan93@163.com)[ ](jiaweifan93@163.com)RECEIVED 01 January 2026 REVISED 15 February 2026 ACCEPTED 18 February 2026 PUBLISHED 06 March 2026  \nCITATION  \nYu Y, Sun L and Fan J (2026) Dual roles of immunosenescence in cancer immunotherapy.  \nFront. Immunol. 17:1779141 .  \ndoi: 10.3389/fimmu.2026.1779141  \nCOPYRIGHT  \n© 2026 Yu, Sun and Fan. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nDual roles of immunosenescencein cancer immunotherapy  \nYe Yu 1, Lei Sun 2* and Jiawei Fan 3*  \n1West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China, 2 Department of Radiation Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Afﬁliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan, China, 3 Department of General Specialized, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital& Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, Sichuan, China  \nCellular senescence of tumor-inﬁltrating immune cells represents a hallmark of tumorigenesis, characterized by functional decline and severely compromised antitumor immunity. A growing body of evidence indicates that immunosenescence isnot only a signiﬁcant biological phenomenon within the tumor microenvironment (TME) but also serves as a therapeutic target with dual regulatory potential. Previous reviews have thoroughly examined the biomarkers associated with immunosenescence and its overarching impact on aging and disease . Nonetheless, comprehensive analyses of its speciﬁc and dual roles in cancer immunotherapy outcomes are still lacking. Consequently, a novel paradigm has been proposed for targeting immunosenescence: modulating the function ofsenescent immune cells may offer innovative cancer treatment strategies. This review synthesizes the bidirectional relationship between immune cell senescence and tumor progression, systematically examining the interactions betweensenescent immune cells and tumor advancement, and underscores the key molecular mechanisms driving immune senescence within the TME. By elucidating the characteristics and functions of immune cell senescence in tumor development and immune evasion, we aim to uncover new therapeutic perspectivesand highlight potential targets for cancer immunotherapy.  \nKEYWORDS  \ncancer immunotherapy, immune cell, immunosenescence, senescence, TME (tumor microenvironment)  \n1 Introduction  \nIn recent years, tumor immunotherapy has revolutionized cancer treatment. Unlike conventional approaches such as chemotherapy and radiotherapy, immunotherapy leverages the host’s immune system to eliminate tumor cells. Notably, therapies targeting immune checkpoints—particularly anti-CTLA-4 and anti-PD-1/PD-L1 monoclonal antibodies—have achieved breakthrough progress in oncology (1) . Among these, antiPD-1/PD-L1 monotherapies (e.g., pembrolizumab, nivolumab, atezolizumab) have shown signiﬁcant efﬁcacy against various cancers, including lung, breast, and colorectal malignancies (2–5) . Critically, chimeric antig","cbCaibfmRDgMUjgu","https://ap.wps.com/l/cbCaibfmRDgMUjgu","pdf",924392,12,"English","# Introduction\n## The development of immune cell senescence","[{\"question\":\"What is immunosenescence in this review?\",\"answer\":\"Immunosenescence is described as a progressive loss of proliferative capacity of immune cells under chronic stimulation, leading to a static state.\"},{\"question\":\"How does immunosenescence relate to the tumor microenvironment (TME)?\",\"answer\":\"Within the TME, senescent immune cells lose tumor-targeting functionality while secreting SASP factors that can promote tumor proliferation, migration, and invasion.\"},{\"question\":\"Why does immunosenescence have “dual roles” in cancer immunotherapy?\",\"answer\":\"The review emphasizes bidirectional interactions where senescent immune cells influence tumor progression, while senescent immune-cell functions also present therapeutic opportunities through modulation of their state.\"}]","Dual roles of immunosenescence in cancer immunotherapy - Review | PDF",1790107747,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5674bf1e9e78cf7d968f82dd8a3d7560.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57620d4407fc8362ff06f19a3d6d4d00.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e867c95a2db467c3a1925587a1862948.webp",981,1386,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3b22479f9036a3cb60ecde962962574.webp",980,1385]